Glycyrrhetinic Acid Exhibits Strong Inhibitory Effects Towards UDP-Glucuronosyltransferase (UGT) 1A3 and 2B7

The UGT1A3*2 polymorphism affects atorvastatin lactonization and lipid-lowering effect in healthy volunteers

(2012) Sung Kweon Cho et al.   Pharmacogenetics and Genomics

Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9

(2012) Liangliang Zhu et al.   XENOBIOTICA

Bioactivation of herbal constituents: simple alerts in the complex system

(2011) Zhong-Ze Fang et al.   Expert Opinion on Drug Metabolism & Toxicology

18β-glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells

(2011) Gunjan Sharma et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Glycyrrhizin and glycyrrhetinic acid directly modulate rat cardiac performance

(2011) Maria L. Parisella et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Investigation of UDP-glucuronosyltransferases (UGTs) Inhibitory Properties of Carvacrol

(2011) Rui-Hua Dong et al.   PHYTOTHERAPY RESEARCH

Spironolactone and Canrenone Inhibit UGT2B7-Catalyzed Human Liver and Kidney Microsomal Aldosterone 18 -Glucuronidation: A Potential Drug Interaction

(2010) K. M. Knights et al.   DRUG METABOLISM AND DISPOSITION

Identification of Human UDP-Glucuronosyltransferase Isoforms Responsible for the Glucuronidation of Glycyrrhetinic Acid

(2010) Yang Lu et al.   Drug Metabolism and Pharmacokinetics

UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib

(2009) Judith Meza-Junco et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Expression of UGT1A and UGT2B mRNA in Human Normal Tissues and Various Cell Lines

(2008) A. Nakamura et al.   DRUG METABOLISM AND DISPOSITION

Glucuronide-sulfate Diconjugate as a Novel Metabolite of Glycyrrhetic Acid in Rat Bile

(2008) Jing Jing et al.   Drug Metabolism and Pharmacokinetics

Antiviral effects ofGlycyrrhiza species

(2007) Cristina Fiore et al.   PHYTOTHERAPY RESEARCH